TrialBritish journal of haematology2019

An open-label phase 2 trial of entospletinib in indolent non-Hodgkin lymphoma and mantle cell lymphoma.

David J Andorsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.